Exercise and Mealworm Protein May Offer Novel Therapeutic Approach to Non-Alcoholic Fatty Liver Disease
Research conducted at Islamic Azad University in Karaj, Iran, suggests that a combination of aerobic exercise and mealworm protein supplementation may provide a novel therapeutic approach to non-alcoholic fatty liver disease (NAFLD). The study, published in the Journal of Exercise & Organ Cross Talk, examined the effects of this integrative strategy on oxidative balance and the expression of FGF21 and mTOR genes in the soleus muscle of rats with NAFLD.
Key Takeaways:
- The study involved 15 male Wistar rats, randomly assigned to five groups: healthy control, fatty liver, fatty liver + supplement, fatty liver + exercise, and fatty liver + supplement + exercise.
- The research found that combined treatment significantly increased FGF21 expression (~130%; p = 0.022), reduced total oxidant status (~40%; p = 0.001), increased total antioxidant capacity (~45%; p = 0.009), and lowered SGPT and ALP levels (~32% and ~38%, respectively; p < 0.05).
- The study suggested that this integrative strategy may offer a novel therapeutic approach targeting liver-muscle metabolic interactions.
- Further human studies are recommended to confirm the findings of this research.
Statistics:
- The rats were divided into five groups, with 15 rats in each group.
- The study found significant increases in FGF21 expression (~130%), total antioxidant capacity (~45%), and reductions in total oxidant status (~40%) and SGPT and ALP levels (~32% and ~38%, respectively).
- The p-values for these findings were 0.022, 0.009, 0.001, and < 0.05, respectively.
Sources:
- The study was published in the Journal of Exercise & Organ Cross Talk,Vol. 4, Issue 4, 2024, pp. 284-291.
- The publisher for Journal of Exercise & Organ Cross Talk is JEOCT publisher.
- A free version of the journal article is available at https://doi.org/10.22122/jeoct.2025.510227.1144.
- The authors of the study are Amir Mounesan, PhD Candidate of Exercise Physiology, Alireza Rahimi, Fariba Aghaei, and Amir Sarshin.